Boston Scientific Corporation
Boston Scientific Corporation’s Price-to-Earnings Ratio at a glance
Boston Scientific Corporation reports price-to-earnings ratio of 70.9x for Dec 2024. The prior period recorded 52.7x (Dec 2023). Year over year the metric moved +18.16 (+34.4%). The rolling three-period average stands at 72.8x. Data last refreshed Dec 18, 2025, 11:38 PM.
Latest reading
70.9x · Dec 2024
YoY movement
+18.16 (+34.4%)
Rolling average
72.8x
Current Price-to-Earnings Ratio
70.9x
+18.16
+34.4%
Rolling average
72.8x
Latest Value
70.9x
Dec 2024
YoY Change
+18.16
Absolute
YoY Change %
+34.4%
Rate of change
3-Period Avg
72.8x
Smoothed
Narrative signal
Boston Scientific Corporation’s price-to-earnings ratio stands at 70.9x for Dec 2024. Year-over-year, the metric shifted by +18.16, translating into a +34.4% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How price-to-earnings ratio shapes Boston Scientific Corporation's story
As of Dec 2024, Boston Scientific Corporation reports price-to-earnings ratio of 70.9x. Analyze price-to-earnings history, valuation swings, and relative multiples to benchmark market expectations.
Why the P/E ratio matters
The price-to-earnings multiple reveals how much investors are willing to pay for each dollar of net income. Elevated P/E levels suggest strong growth expectations or limited earnings.
Tracking valuation cycles
Monitoring multi-year P/E trends highlights how macro cycles, product launches, or profitability changes impact valuation over time.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
61.3%
Operating Margin
15.7%
Net Profit Margin
11.1%
Return on Equity
8.5%
Return on Assets
4.7%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Boston Scientific Corporation (BSX) FAQs
Answers tailored to Boston Scientific Corporation’s price-to-earnings ratio profile using the latest Financial Modeling Prep data.
What is Boston Scientific Corporation's current price-to-earnings ratio?
As of Dec 2024, Boston Scientific Corporation reports price-to-earnings ratio of 70.9x. This reading reflects the latest filings and price data for BSX.
How is Boston Scientific Corporation's price-to-earnings ratio trending year over year?
Year-over-year, the figure shifts by +18.16 (+34.4%). Pair this context with revenue growth and free cash flow signals to gauge momentum for BSX.
Why does price-to-earnings ratio matter for Boston Scientific Corporation?
The P/E ratio compares a company’s share price with its per-share earnings to gauge valuation. For Boston Scientific Corporation, operating within Healthcare — Medical - Devices, tracking this metric helps benchmark management's execution against close competitors.
Is Boston Scientific Corporation's price-to-earnings ratio above its recent average?
Boston Scientific Corporation's rolling three-period average sits at 72.8x. Comparing the latest reading of 70.9x to that baseline highlights whether momentum is building or fading for BSX.
How frequently is Boston Scientific Corporation's price-to-earnings ratio refreshed?
Data for BSX was last refreshed on Dec 18, 2025, 11:38 PM and updates automatically every 24 hours, keeping your valuation inputs current.